BabjukM, BurgerM, ZigeunerR, et al.EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2013. Eur Urol, 2013; 64:639–653.
2.
KakizoeT. Development and progression of urothelial carcinoma. Cancer Sci, 2006; 97:821–828.
3.
SlaughterDP, SouthwickHW, SmejkalW. Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer, 1953; 6:963–968.
4.
SidranskyD, FrostP, Von EschenbachA, et al.Clonal origin bladder cancer. N Engl J Med, 1992; 326:737–740.
5.
MangrudOM, WaalenR, GudlaugssonE, et al.Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder. PloS One. 2014; 9:e83192.
6.
WitjesJA, MoonenPM, van der HeijdenAG. Review pathology in a diagnostic bladder cancer trial: Effect of patient risk category. Urology, 2006; 67:751–755.
7.
MayM, Brookman-AmissahS, RoigasJ, et al.Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: A multicentre study comparing the 1973 and 2004 World Health Organisation classifications. Eur Urol, 2010; 57:850–858.
8.
KleinR, KleinBE. The prevalence of age-related eye diseases and visual impairment in aging: Current estimates. Invest Ophthalmol Vis Sci, 2013; 54:ORSF5-ORSF13.
9.
OwsleyC. Aging and vision. Vision Res, 2011; 51:1610–1622.
10.
SjostrandJ, LaatikainenL, HirvelaH, et al.The decline in visual acuity in elderly people with healthy eyes or eyes with early age-related maculopathy in two Scandinavian population samples. Acta Ophthalmol, 2011; 89:116–123.
11.
CinaSJ, EpsteinJI, EndrizziJM, et al.Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder. Hum Patholo, 2001; 32:630–637.
12.
DobruchJ, BorowkaA, HerrHW. Clinical value of transurethral second resection of bladder tumor: Systematic review. Urology, 2014; 84:881–885.
13.
HerrHW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol, 1999; 162:74–76.
14.
MariappanP, FinneySM, HeadE, et al.Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: Validation across time and place and recommendation for benchmarking. BJU Int, 2012; 109:1666–1673.
15.
RinkM, BabjukM, CattoJW, et al.Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: A critical review of the current literature. Eur Urol, 2013; 64:624–638.
16.
YeoL, JainS. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: Validation across time and place and recommendation for benchmarking. BJU Int, 2012; 109:E27.
17.
BrausiM, ColletteL, KurthK, et al.Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol, 2002; 41:523–531.
GeavleteB, MultescuR, GeorgescuD, et al.Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors—results of a prospective, randomized comparison to the standard approach. Urology, 2012; 79:846–851.
